We Did The Math IWV Can Go To $215

Start slideshow:
10 ETFs With Most Upside To Analyst Targets »

With IWV trading at a recent price near $195.42 per unit, that means that analysts see 9.93% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IWV's underlying holdings with notable upside to their analyst target prices are Tricida Inc (TCDA), OptiNose Inc (OPTN), and Minerva Neurosciences Inc (NERV). Although TCDA has traded at a recent price of $8.87/share, the average analyst target is 373.51% higher at $42.00/share. Similarly, OPTN has 367.48% upside from the recent share price of $3.69 if the average analyst target price of $17.25/share is reached, and analysts on average are expecting NERV to reach a target price of $13.62/share, which is 331.17% above the recent price of $3.16. Below is a twelve month price history chart comparing the stock performance of TCDA, OPTN, and NERV:

Below is a summary table of the current analyst target prices discussed above:

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on TCDA — FREE
Get the latest Zacks research report on OPTN — FREE
Get the latest Zacks research report on NERV — FREE